Merck’s $1.35 Billion Acquisition of Imago BioSciences, Inc.

Goodwin Procter advised Centerview Partners on the deal, Latham & Watkins represented Imago BioSciences, Gibson Dunn & Crutcher advised Merck.Merck (NYSE: MRK) and Imago BioSciences, Inc. (Nasdaq:…

This content is for Standard 1 Year members only.
Login Join Now
Martina Bellini

Author: Martina Bellini

This content is for Standard 1 Year members only.
Login Join Now